BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 8630426)

  • 1. A gene transfer strategy for making bone marrow cells resistant to trimetrexate.
    Spencer HT; Sleep SE; Rehg JE; Blakley RL; Sorrentino BP
    Blood; 1996 Mar; 87(6):2579-87. PubMed ID: 8630426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased resistance to nitrogen mustards and antifolates following in vitro selection of murine fibroblasts and primary hematopoietic cells transduced with a bicistronic retroviral vector expressing the rat glutathione S-transferase A3 and a mutant dihydrofolate reductase.
    Belzile JP; Karatzas A; Shiu HY; Létourneau S; Palerme JS; Cournoyer D
    Cancer Gene Ther; 2003 Aug; 10(8):637-46. PubMed ID: 12872145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retroviral vectors containing a variant dihydrofolate reductase gene for drug protection and in vivo selection of hematopoietic cells.
    Allay JA; Galipeau J; Blakley RL; Sorrentino BP
    Stem Cells; 1998; 16 Suppl 1():223-33. PubMed ID: 11012166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complete regression of large solid tumors using engineered drug-resistant hematopoietic cells and anti-CD137 immunotherapy.
    McMillin DW; Hewes B; Gangadharan B; Archer DR; Mittler RS; Spencer HT
    Hum Gene Ther; 2006 Aug; 17(8):798-806. PubMed ID: 16942440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trimetrexate inhibits progression of the murine 32Dp210 model of chronic myeloid leukemia in animals expressing drug-resistant dihydrofolate reductase.
    Sweeney CL; Frandsen JL; Verfaillie CM; McIvor RS
    Cancer Res; 2003 Mar; 63(6):1304-10. PubMed ID: 12649191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of dual resistance to 4-hydroperoxycyclophosphamide and methotrexate by retroviral transfer of the human aldehyde dehydrogenase class 1 gene and a mutated dihydrofolate reductase gene.
    Takebe N; Zhao SC; Adhikari D; Mineishi S; Sadelain M; Hilton J; Colvin M; Banerjee D; Bertino JR
    Mol Ther; 2001 Jan; 3(1):88-96. PubMed ID: 11162315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sensitization of hematopoietic stem and progenitor cells to trimetrexate using nucleoside transport inhibitors.
    Allay JA; Spencer HT; Wilkinson SL; Belt JA; Blakley RL; Sorrentino BP
    Blood; 1997 Nov; 90(9):3546-54. PubMed ID: 9345038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protection of CCRF-CEM human lymphoid cells from antifolates by retroviral gene transfer of variants of murine dihydrofolate reductase.
    Mareya SM; Sorrentino BP; Blakley RL
    Cancer Gene Ther; 1998; 5(4):225-35. PubMed ID: 9694074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the protection of cells from antifolates by transduced human dihydrofolate reductase mutants.
    Patel M; Sleep SE; Lewis WS; Spencer HT; Mareya SM; Sorrentino BP; Blakley RL
    Hum Gene Ther; 1997 Nov; 8(17):2069-77. PubMed ID: 9414255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cells exposed to antifolates show increased cellular levels of proteins fused to dihydrofolate reductase: a method to modulate gene expression.
    Mayer-Kuckuk P; Banerjee D; Malhotra S; Doubrovin M; Iwamoto M; Akhurst T; Balatoni J; Bornmann W; Finn R; Larson S; Fong Y; Gelovani Tjuvajev J; Blasberg R; Bertino JR
    Proc Natl Acad Sci U S A; 2002 Mar; 99(6):3400-5. PubMed ID: 11891321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A bicistronic retroviral vector for protecting hematopoietic cells against antifolates and P-glycoprotein effluxed drugs.
    Galipeau J; Benaim E; Spencer HT; Blakley RL; Sorrentino BP
    Hum Gene Ther; 1997 Oct; 8(15):1773-83. PubMed ID: 9358027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retroviral coexpression of thymidylate synthase and dihydrofolate reductase confers fluoropyrimidine and antifolate resistance.
    Fantz CR; Shaw D; Moore JG; Spencer HT
    Biochem Biophys Res Commun; 1998 Feb; 243(1):6-12. PubMed ID: 9473470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo selection of antifolate-resistant transgenic hematopoietic stem cells in a murine bone marrow transplant model.
    Warlick CA; Diers MD; Wagner JE; McIvor RS
    J Pharmacol Exp Ther; 2002 Jan; 300(1):50-6. PubMed ID: 11752096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term protection of recipient mice from lethal doses of methotrexate by marrow infected with a double-copy vector retrovirus containing a mutant dihydrofolate reductase.
    Zhao SC; Li MX; Banerjee D; Schweitzer BI; Mineishi S; Gilboa E; Bertino JR
    Cancer Gene Ther; 1994 Mar; 1(1):27-33. PubMed ID: 7621235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of methotrexate resistance conferred by a mutated dihydrofolate reductase (DHFR) cDNA in two different retroviral vectors.
    Takebe N; Nakahara S; Zhao SC; Adhikari D; Ural AU; Iwamoto M; Banerjee D; Bertino JR
    Cancer Gene Ther; 2000 Jun; 7(6):910-9. PubMed ID: 10880023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ex vivo expansion and selection of human CD34+ peripheral blood progenitor cells after introduction of a mutated dihydrofolate reductase cDNA via retroviral gene transfer.
    Flasshove M; Banerjee D; Mineishi S; Li MX; Bertino JR; Moore MA
    Blood; 1995 Jan; 85(2):566-74. PubMed ID: 7529065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The murine-reduced folate carrier gene can act as a selectable marker and a suicide gene in hematopoietic cells in vivo.
    Liu S; Song L; Bevins R; Birhiray O; Moscow JA
    Hum Gene Ther; 2002 Sep; 13(14):1777-82. PubMed ID: 12396629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective expression of methotrexate-resistant dihydrofolate reductase (DHFR) activity in mice transduced with DHFR retrovirus and administered methotrexate.
    Vinh DB; McIvor RS
    J Pharmacol Exp Ther; 1993 Nov; 267(2):989-96. PubMed ID: 8246174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transfection of a nonactive site mutant murine DHFR cDNA (the tryptophan 15 mutant) into Chinese hamster ovary and mouse marrow progenitor cells imparts MTX resistance in vitro.
    Banerjee D; Zhao SC; Tong Y; Steinherz J; Gritsman K; Bertino JR
    Cancer Gene Ther; 1994 Sep; 1(3):181-4. PubMed ID: 7621249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Mice transduced with double-mutant dihydrofolate reductase-cytidine deaminase fusion gene attained protection from high dose chemotherapy].
    Lu P; Lu Y; Pang K; Wang SB; Chen JQ; Xu HM; Wang JK; Zhao SC
    Zhonghua Wai Ke Za Zhi; 2005 Aug; 43(15):998-1001. PubMed ID: 16194358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.